What is the official website of Fresenius Kabi France ?

The official website of Fresenius Kabi France is http://www.fresenius-kabi.fr/.

What is Fresenius Kabi France's cybersecurity risk score?

Fresenius Kabi France has an AI-generated cybersecurity risk score of 755 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Fresenius Kabi France experienced?

According to Rankiteo, Fresenius Kabi France currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Fresenius Kabi France been affected by any supply chain cyber incidents ?

According to Rankiteo, Fresenius Kabi France has been affected by a supply chain cyber incident involving Fresenius Kabi USA, with the incident ID FRE1781735374.

Does Fresenius Kabi France have SOC 2 Type 1 certification ?

According to Rankiteo, Fresenius Kabi France is not certified under SOC 2 Type 1.

Does Fresenius Kabi France have SOC 2 Type 2 certification ?

According to Rankiteo, Fresenius Kabi France does not hold a SOC 2 Type 2 certification.

Does Fresenius Kabi France comply with GDPR ?

According to Rankiteo, Fresenius Kabi France is not listed as GDPR compliant.

Does Fresenius Kabi France have PCI DSS certification ?

According to Rankiteo, Fresenius Kabi France does not currently maintain PCI DSS compliance.

Does Fresenius Kabi France comply with HIPAA ?

According to Rankiteo, Fresenius Kabi France is not compliant with HIPAA regulations.

Does Fresenius Kabi France have ISO 27001 certification ?

According to Rankiteo,Fresenius Kabi France is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Fresenius Kabi France operate in ?

Fresenius Kabi France operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does Fresenius Kabi France have ?

Fresenius Kabi France employs approximately 452 people worldwide.

Does Fresenius Kabi France own any subsidiaries ?

Fresenius Kabi France presently has no subsidiaries across any sectors.

How many LinkedIn followers does Fresenius Kabi France have ?

Fresenius Kabi France's official LinkedIn profile has approximately 20,716 followers.

What is the NAICS classification code for Fresenius Kabi France ?

Fresenius Kabi France is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does Fresenius Kabi France have a Crunchbase profile ?

No, Fresenius Kabi France does not have a profile on Crunchbase.

Does Fresenius Kabi France have a LinkedIn profile ?

Yes, Fresenius Kabi France maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/freseniuskabifrance.

How many cybersecurity incidents has Fresenius Kabi France experienced ?

As of September 30, 2026, Rankiteo reports that Fresenius Kabi France has experienced 3 cybersecurity incidents.

How many peer or competitor companies does Fresenius Kabi France have ?

Fresenius Kabi France has an estimated 5,771 peer or competitor companies worldwide.

What types of cybersecurity incidents has Fresenius Kabi France faced ?

Incident Types: The types of cybersecurity incidents that have occurred include Breach and Ransomware.

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

FKF

Boost Score +25 with badge (5 left)

755

/1000

Fair

780

/1000

Fair

Fresenius Kabi France Vendor Cyber Rating & Cyber Score

fresenius-kabi.fr

Add Your Compliance Badge

Fresenius Kabi est une entreprise de santé mondiale spécialisée dans les médicaments et les dispositifs médicaux vitaux dans la perfusion, la transfusion et la nutrition clinique. Les médicaments, technologies et services de Fresenius Kabi sont utilisés pour aider à soigner les patients en situation d’urgence ou atteints de maladies chroniques. Le portefeuille de produits de Fresenius Kabi comprend une gamme complète de médicaments génériques administrés par voie intraveineuse, des thérapies par perfusion, des produits de nutrition clinique ainsi que les dispositifs médicaux nécessaires à l’administration de ces produits. Dans le domaine des biosimilaires, nous nous concentrons sur les maladies auto-immunes et l'oncologie. En 2019, le

FKF

Fresenius Kabi France CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

Fresenius Kabi USA

Breach

100

1/2026

Fresenius Kabi ...

FRE1781735374

Fresenius Group

Ransomware

100

5/2020

FRE1770566194

Fresenius Kabi Fran...

Ransomware

05/2020

FRE2038291222

Loading…

A.I.

FKF Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for FKF

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Fresenius Kabi France in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Fresenius Kabi France in 2026.

Incident Types FKF vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Fresenius Kabi France in 2026.

Incident History - FKF (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Fresenius Kabi France Subsidiaries

FKF

Pharmaceutical Manufacturing

Website: http://www.fresenius-kabi.fr/

Company Size: 452

Fresenius KabiPharmaceutical Manufacturing

Fresenius Kabi USAPharmaceutical Manufacturing

Fresenius GroupHospitals and Health Care

Fresenius Investor RelationsHospitals and Health Care

Helios Health GmbHHospitals and Health Care

Fresenius Kabi ItaliaPharmaceutical Manufacturing

Fresenius Kabi BrasilPharmaceutical Manufacturing

Fresenius Kabi UKPharmaceutical Manufacturing

MOTIV eLearningHospitals and Health Care

Fresenius Kabi ArgentinaPharmaceutical Manufacturing

Fresenius Kabi CanadaPharmaceutical Manufacturing

Fresenius Kabi MedTech EuropeMedical Equipment Manufacturing

Fresenius Kabi EspañaPharmaceutical Manufacturing

Fresenius Kabi ChilePharmaceutical Manufacturing

Fresenius Kabi EuropePharmaceutical Manufacturing

Fresenius Kabi AustriaPharmaceutical Manufacturing

Fresenius Kabi Australia and New ZealandPharmaceutical Manufacturing

Fresenius Kabi EcuadorPharmaceutical Manufacturing

Fresenius Kabi PortugalPharmaceutical Manufacturing

Fresenius Kabi PolskaPharmaceutical Manufacturing

Fresenius Kabi South AfricaPharmaceutical Manufacturing

Fresenius Kabi Business ServicesAccounting

Fresenius Kabi DanmarkPharmaceutical Manufacturing

Fresenius Kabi IrelandPharmaceutical Manufacturing

Fresenius Kabi NetherlandsPharmaceutical Manufacturing

Fresenius Kabi BelgiumPharmaceutical Manufacturing

Fresenius Kabi SchweizPharmaceutical Manufacturing

Fresenius Kabi Puerto RicoManufacturing

Fresenius Kabi (Singapore) Pte Ltd, SingaporePharmaceutical Manufacturing

Fenwal, Inc., a Fresenius Kabi CompanyMedical Equipment Manufacturing

Fresenius Kabi ColombiaPharmaceutical Manufacturing

Loading…

Fresenius Kabi France Similar Companies

Cipla

cipla.com

Cipla is a leading global pharmaceutical company trusted by healthcare professionals and patients across the world since 1935. A compassionate approach to healthcare that goes beyond the pursuit of profit and growth has been the force impelling Cipla’s history over the years. Our credo and our purpose of ‘Caring for Life' continues to guide our actions towards our people and the planet for creating a sustainable future. Cipla today has presence in 80+ countries, providing over 1,500 products across various therapeutic categories in 50+ dosage forms. Keeping with our legacy of care, we constantly strive to ensure access to high-quality medicines that make a difference in the lives of patients. Our paradigm-changing offer of a triple anti-retroviral (ARV) therapy in HIV/AIDS at less than a dollar a day in Africa in 2001 was pivotal in bringing inclusiveness, accessibility and affordability to the centre of the HIV movement. An unmatched presence across the care continuum (awareness, prevention, diagnosis, treatment and adherence) and the widest range of drug-device combinations has established Cipla’s respiratory leadership in India and other key emerging markets. Armed with this legacy and a deep understanding of the lungs, we have articulated our aspiration to become a global lung leader and help millions breathe free.

Merck

merck.us

At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.merck.com. This site is intended for residents of the United States and Canada and their territories only. FLS: http://merck.us/3TKXNuZ

Teva Pharmaceuticals

tevapharm.com

Teva Pharmaceuticals is a leading innovative biopharmaceutical company, enabled by a world-class generics business. For over 120 years, Teva’s commitment has never wavered. From innovating in the fields of neuroscience and immunology to providing complex generic medicines, biosimilars and pharmacy brands worldwide, Teva is dedicated to addressing patients’ needs, now and in the future. At Teva, We Are All In For Better Health. To learn more about how we make it happen, visit www.tevapharm.com. Our community guidelines may be found here: https://www.tevapharm.com/news-and-media/teva-social-media-guidelines/ Please note that adverse effects for any of our products should be reported at: https://www.tevapharm.com/teva-medical-information/report-a-side-effect-form/ Product-specific questions should be directed to Teva or Teva Group subsidiaries in your country. Contact details and Teva's Pharmacovigilance Privacy Policy may be found here: http://www.tevapharm.com/contact_us/

Astellas Pharma

astellas.com

Astellas is a global life sciences company committed to turning innovative science into VALUE for patients. We provide transformative therapies in disease areas that include oncology, ophthalmology, urology, immunology and women's health. Through our research and development programs, we are pioneering new healthcare solutions for diseases with high unmet medical need. Visit our Global Astellas LinkedIn Community Guidelines to learn more about interacting with this page: https://www.astellas.com/en/global-linkedin-community-guidelines

Torrent Pharmaceuticals Ltd

cb torrentpharma.com

Torrent Pharma, with annual revenues of more than Rs 10,700 crores, is the flagship Company of the Torrent Group, with group revenues of Rs 41,000 crores. It is ranked 5th in the Indian Pharma Market and is among the Top 5 in the therapeutic segments of Cardiovascular (CV), Central Nervous System (CNS), Gastro-intestinal (GI), Vitamins Minerals Nutritionals (VMN) and Cosmo-Dermatology. The Company also has significant presence in diabetology, pain management, gynaecology, oncology and anti-infective segments. Torrent has 8 manufacturing facilities , of which 5 are USFDA approved. With R&D as the backbone for its growth in domestic & overseas market, it has invested significantly in R&D capabilities with state-of-the-art R&D infrastructure employing around 800 scientists. The acquisition of Elder Pharma's Indian branded business in 2013, Dermaceuticals business of Zyg Pharma in 2015, API plant of Glochem Industries in 2016, Women healthcare brands from Novartis and Unichem's Indian branded business along with its Sikkim Plant in 2017 strengthened Torrent Pharma's position in the Indian Pharma market. Torrent Pharma started international acquisitions in 2005 with entry into the German market. Today, the Company has presence in more than 50 countries and is ranked No. 1 among the Indian pharma Companies in Brazil and Germany. Torrent Pharma is committed towards “not just healthcare but lifecare.”

Lonza

lonza.com

Lonza is a pioneer and world leader in the CDMO industry, setting the pace with cutting-edge science, smart technology, and lean manufacturing. United by a common purpose, we turn our customers’ breakthrough innovations into viable therapies and manufacture the medicines of tomorrow. Founded in Switzerland in 1897, our company is the first and original CDMO, and today we are more dynamic, agile and forward-focused than ever before. As one of the largest Western CDMOs, we bring together a global team of around 18,500 colleagues across five continents to deliver comprehensive, integrated solutions for our customers' complex needs. For our customers and their patients, we bring quality, safety and reliability to bring life-enhancing and life-saving treatments to market at speed and at scale. For our colleagues, we strive to create a sense of belonging and inclusion where every person can thrive and bring their best.

Takeda

cb takeda.com

We strive to transform lives. While the science we advance is constantly evolving, our core purpose is enduring. For more than two centuries, our values have guided us to do what’s right for patients and for society. We know that changing lives requires us to do things differently. We start by listening to and addressing what really matters to patients, the people who love them, and those in the healthcare system who provide care. And that’s what inspires us all to be bold, push boundaries and set new standards that open up greater opportunities. Read our community guidelines: https://takeda.info/communityguidelines

Merck Group

merckgroup.com

This channel is not intended for U.S. and Canadian visitors. Merck operates in the U.S. and Canada as EMD Serono in Healthcare, MilliporeSigma in Life Science and EMD Electronics in Electronics. An unaffiliated and unrelated company, Merck & Co., Inc., Kenilworth, NJ, US holds the rights in the trademark MERCK in the U.S. and Canada. _______________________________ We are Merck, a leading global science and technology company headquartered in Germany. We are curious explorers, courageous pioneers, and ingenious inventors. Our colleagues across the globe love innovating with science and technology to enrich people’s lives with our solutions in Life Science, Healthcare, and Electronics. Together, we dream big and are passionate about caring for our rich mix of people, customers, patients, and the planet. We believe in the positive power of science and technology. It has determined our actions since 1668 and inspires us to continue researching for a future worth living. As a family-owned company with over 350 years of experience, we stand for sustainability, responsibility, and innovative strength. We take pride in being a diverse and inclusive company that values and fosters the talents and abilities of our employees. That's why we are always looking for curious minds that see themselves imagining the unimaginable with us. Work your Magic and join Merck. Legal Disclaimer: www.merckgroup.com/en/legal-disclaimer.html Data Privacy Declaration: www.merckgroup.com/en/privacy-statement

SUN PHARMA

sunpharma.com

Sun Pharma is the world's fourth-largest speciality generic pharmaceutical company and No. 1 in India. We provide high-quality, affordable medicines trusted by customers and patients in over 100 countries. Sun Pharma's global presence is supported by more than 40 manufacturing facilities spread across 5 continents, R&D centres across the globe, and a multicultural workforce comprising over 50 nationalities. Sun Pharma fosters excellence through innovation supported by strong R&D capabilities comprising around 3,000 scientists and R&D investments of over 6-8% of annual revenues. At Sun, our people are our greatest asset. Ours has never been a story of individual brilliance but of cultivating a culture of realising collective potential. In our journey, everyone is enabled to take charge in an environment that offers limitless growth opportunities. We are with you every step of the way, so you can shine for years to come. With the launch of our Employee Value Proposition (EVP), we define our promise to ‘Create Your Own Sunshine'—driven by the three pillars of Better Every Day, Take Charge, and Thrive Together. These pillars drive progress at Sun so that people can achieve what they would have thought impossible. Learn more about our EVP here: https://sunpharma.com/careers/

Loading…

NEWS

Fresenius Kabi France CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

December 22, 2021 08:00 AM

FDA, CISA Warn of Fresenius Kabi Infusion Pump Flaws

US government authorities have issued an advisory warning about remotely exploitable security vulnerabilities in certain Fresenius Kabi infusion pump systems.

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-103047

SUMMARY

Improper neutralization of input during web page generation ('cross-site scripting') vulnerability in The Wikimedia Foundation Mediawiki - CentralAuth extension allows Stored XSS. This issue affects Mediawiki - CentralAuth extension: before 1.46.1, 1.45.5, 1.43.10.

Published

Date2026-09-29

Updated

Date2026-09-29

RISK INFORMATION (Score: )

Impact Score

Exploitability

REFERENCES

CVE-2026-103046

SUMMARY

Improper neutralization of input during web page generation ('cross-site scripting') vulnerability in Wikimedia Foundation MediaWiki - WikiLambda extension allows Stored XSS. This issue affects MediaWiki - WikiLambda extension: before 1.46.1.

Published

Date2026-09-29

Updated

Date2026-09-29

RISK INFORMATION (Score: )

Impact Score

Exploitability

REFERENCES

CVE-2026-103045

SUMMARY

Improper neutralization of input during web page generation ('cross-site scripting') vulnerability in The Wikimedia Foundation Mediawiki - Refreshed skin allows Stored XSS. This issue affects Mediawiki - Refreshed skin: before 1.46.1, 1.45.5, 1.43.10.

Published

Date2026-09-29

Updated

Date2026-09-29

RISK INFORMATION (Score: )

Impact Score

Exploitability

REFERENCES

CVE-2026-103044

SUMMARY

XML injection (aka blind XPath injection) vulnerability in The Wikimedia Foundation Mediawiki - EasyTimeline extension allows XML Injection. This issue affects Mediawiki - EasyTimeline extension: before 1.46.1, 1.45.5, 1.43.10.

Published

Date2026-09-29

Updated

Date2026-09-29

RISK INFORMATION (Score: )

Impact Score

Exploitability

REFERENCES

CVE-2026-103043

SUMMARY

anchorme through 3.0.8 contains a regular expression denial of service vulnerability in the IPv6 host extraction regex due to catastrophic backtracking. Attackers can supply specially crafted input strings with repeated patterns to cause exponential regex engine backtracking, blocking the Node.js event loop and denying service to other requests.

Published

Date2026-09-29

Updated

Date2026-09-29

RISK INFORMATION (Score: 7.5)

cvss3

Base Score: 7.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H

cvss4

Base Score: 8.7

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.6

Exploitability

3.9

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…

Badge your company to reduce your risk score and your cyber insurance costs!

Trusted by insurers. Chosen by leaders.

Fresenius Kabi France Vendor Cyber Rating & Cyber Score

FKF A.I CyberSecurity Scoring

Fresenius Kabi France CyberSecurity News & History

FKF Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for FKF

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types FKF vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incident History - FKF (X = Date, Y = Severity)

Fresenius Kabi France Subsidiaries

FKF

Fresenius Kabi France Similar Companies

Cipla

Merck

Teva Pharmaceuticals

Astellas Pharma

Torrent Pharmaceuticals Ltd

Lonza

Takeda

Merck Group

SUN PHARMA

Fresenius Kabi France CyberSecurity News

FDA, CISA Warn of Fresenius Kabi Infusion Pump Flaws

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo

Fresenius Kabi France CyberSecurity News & History

FKF Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for FKF

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types FKF vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incident History - FKF (X = Date, Y = Severity)

Fresenius Kabi France Subsidiaries

FKF

Fresenius Kabi France Similar Companies

Cipla

Merck

Teva Pharmaceuticals

Astellas Pharma

Torrent Pharmaceuticals Ltd

Lonza

Takeda

Merck Group

SUN PHARMA

Fresenius Kabi France CyberSecurity News

FDA, CISA Warn of Fresenius Kabi Infusion Pump Flaws

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo